Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, August 5 2015 6:32am ET - U.S. Markets open in 2 hours and 58 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Diagnostic Substances News
Latest News
Tuesday, Aug 4, 2015
·Nymox Announces Change of Company's Domicile and Head Office
GlobeNewswire - Tue 11:45 am ET
·Oxford Immunotec reports 2Q loss
AP - Tue 8:06 am ET
·Breakthrough SDMA Kidney Function Test Now Available from IDEXX Canada
CNW Group - Tue 8:00 am ET
·Oxford Immunotec Reports Second Quarter 2015 Financial Results
GlobeNewswire - Tue 7:00 am ET
Friday, Jul 31, 2015
·IDEXX Laboratories to Host 2015 Analyst Day
PR Newswire - Fri Jul 31
Thursday, Jul 30, 2015
·AMAG Pharmaceuticals Prices Public Offering of $201 Million of Common Stock
GlobeNewswire - Thu Jul 30
·An Animal of a Quarter for IDEXX
at Motley Fool - Thu Jul 30
·IDEXX Laboratories Soars Following Its Q2 Results
at Motley Fool - Thu Jul 30
·Nymox Announces Appointment of James G. Robinson to Board of Directors
GlobeNewswire - Thu Jul 30
·Idexx tops 2Q profit forecasts
AP - Thu Jul 30
·Vermillion to Report Second Quarter 2015 Financial Results and Host Investor Conference Call on August 13
PR Newswire - Thu Jul 30
·IDEXX Laboratories Announces Second Quarter Results
PR Newswire - Thu Jul 30
Wednesday, Jul 29, 2015
·AMAG Pharmaceuticals Announces Proposed Public Offering of $200 Million of Common Stock
GlobeNewswire - Wed Jul 29
·Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders
PR Newswire - Wed Jul 29
Tuesday, Jul 28, 2015
·Nymox Pharmaceutical (NYMX) Stock Higher on Positive Test Results
at TheStreet.com - Tue Jul 28
·Nymox July 27 Webcast of New BPH Clinical Trial Results Posted Today Online
GlobeNewswire - Tue Jul 28
·Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed
GlobeNewswire - Tue Jul 28
·SurModics to Webcast Third Quarter 2015 Earnings Conference Call on August 5
Business Wire - Tue Jul 28
Monday, Jul 27, 2015
·Can Nymox Sustain This Massive Rally?
- Mon Jul 27
·SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. – AMAG
- Mon Jul 27
More Latest News...
Sponsor Results
AdvaMed Certificate
Medical Device Certificate for Both QA and Compliance Professionals
www.uleduneering.com
DME Software
Go Paperless DME Software That Works
www.dmeworks.com
MedNet DME Billing Srvcs
DME Billing Expert/Consulting with over 20 yrs experience to utilize!
www.mednetinc.net
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?